EUVIMEDEUVIMED entdecken
FallberichtOpen Access

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53

Karlo Perica, Nayan Jain, Michael Scordo, Ruchi Patel, Ozgur Can Eren iD, Utsav Patel, Gunes Gundem, Dylan Domenico, Sneha Mitra, Nicholas D Socci, John K Everett, Aoife M Roche und 14 weitere

New England Journal of Medicine · 06.02.2025 · 392 (6) · 577-583

DOI: 10.1056/nejmoa2411507 ↗

Kurz gefasst

Fallbericht in der Zeitschrift New England Journal of Medicine, erschienen am 06.02.2025. Verfasst von Karlo Perica und 25 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. Hauptthemen laut MEDLINE: B-Cell Maturation Antigen, Immunotherapy, Adoptive, Lymphoma, T-Cell, Multiple Myeloma. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Leukemia and Lymphoma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-Cell Maturation AntigenImmunotherapy, AdoptiveLymphoma, T-CellMultiple MyelomaTumor Suppressor Protein p53HumansCD4-Positive T-LymphocytesCell Transformation, NeoplasticLentivirusReceptors, Chimeric AntigenFemaleAgedFatal Outcome

Substanzen

B-Cell Maturation AntigenReceptors, Chimeric AntigenTP53 protein, humanTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
  • Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York.
  • Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
  • Department of Medicine, Weill Cornell Medical College, New York.
  • Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York.
  • Hematopathology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York.

ORCID-Profile: Ozgur Can Eren, Angelina Petrichenko, Jae H Park, Frederic D Bushman

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Leukemia and Lymphoma Society

Zitieren

APA

Perica, K., Jain, N., Scordo, M., Patel, R., Eren, O. C., Patel, U., Gundem, G., Domenico, D., Mitra, S., Socci, N. D., Everett, J. K., Roche, A. M., Petrichenko, A., Shah, G. L., Arcila, M. E., Borsu, L., Park, J. H., Horwitz, S. M., Giralt, S. A., …, & Mailankody, S. (2025). CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53. New England Journal of Medicine, 392(6), 577-583. https://doi.org/10.1056/nejmoa2411507

Vancouver

Perica K, Jain N, Scordo M, Patel R, Eren OC, Patel U, et al. CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53. New England Journal of Medicine. 2025;392(6):577-583. doi:10.1056/nejmoa2411507

BibTeX
@article{Perica2025,
  author = {Perica, Karlo and Jain, Nayan and Scordo, Michael and Patel, Ruchi and Eren, Ozgur Can and Patel, Utsav and Gundem, Gunes and Domenico, Dylan and Mitra, Sneha and Socci, Nicholas D and Everett, John K and Roche, Aoife M and Petrichenko, Angelina and Shah, Gunjan L and Arcila, Maria E and Borsu, Laetitia and Park, Jae H and Horwitz, Steven M and Giralt, Sergio A and Dogan, Ahmet and Leslie, Christina and Papaemmanuil, Elli and Bushman, Frederic D and Usmani, Saad Z and Sadelain, Michel and Mailankody, Sham},
  title = {CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {6},
  pages = {577--583},
  doi = {10.1056/nejmoa2411507}
}
Kostenlos starten →